Abstract:Manjun Ye, &ast Lixia Zhang &ast Department of Oral Surgery, Daqing Oilfield General Hospital, Daqing, Heilongjiang, 163000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Manjun Ye, Department of Oral Surgery, Daqing Oilfield General Hospital, No. 9 Zhongkang Street, Ertu District, Daqing, Heilongjiang, 163000, People's Republic of China, Email Introduction: This study aimed to explore the correlation of systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) with the recurrence and prognosis in patients with advanced oral squamous cell carcinoma (OSCC). Methods: A total of 298 OSCC patients with the stage of III/IV were finally included in the study. SII = neutrophil count (10 9 /L) × platelet count (10 9 /L)/lymphocyte count (10 9 /L). PNI = serum albumin (g/L) + 5 × total lymphocyte count (10 9 /L). Results: High preoperative SII and low preoperative PNI were independent risk factors for tumor recurrence in OSCC patients of the stage of III/IV. The area under the curves (AUC) for SII was 0.69 (0.63 to 0.76), for PNI was 0.72 (0.67 to 0.78), and for joint model was 0.81 (0.76 to 0.85). Patients with low level of joint model had significantly higher overall survival rate for 5 years follow-up than those with high level. Discussion: Both preoperative SII and PNI are valuable independent tumor recurrence prediction index in patients with advanced OSCC. Meanwhile, the combination of preoperative SII and PNI is also valuable on OSCC recurrence and prognosis prediction. Keywords: oral squamous cell carcinoma, prognostic nutritional index, systemic immune-inflammation index, recurrence, prognosis Oral squamous cell carcinoma (OSCC) is aggressive. Studies have shown that the incidence and mortality of OSCC in rural and urban China are on the rise. 1 The prognosis of patients with OSCC is affected by many factors. Although the level of diagnosis and treatment of oral cancer has been improved worldwide, the prognosis of OSCC patients has not been significantly improved. Tumor recurrence is still the main cause of death in patients. Patients with recurrence have lower 5-year overall survival rate than patients without recurrence. 2 How to accurately implement individualized treatment and scientifically evaluate the prognosis of patients with advanced OSCC has important clinical significance. The impact of malnutrition on disease prognosis is manifested in multiple ways. 3 First, the occurrence of malnutrition leads to the decline of the function of various organs of the body and the imbalance of components leads to the decline of the functions of various systems. Second, malnutrition can lead to a compromised immune system. Prognostic nutritional index (PNI) is a widely used index based on total lymphocyte counts and serum albumin (ALB) levels. 4 Preoperative systemic inflammatory response participates in tumor development and consequently to overall survival. 5 Systemic immune-inflammation index (SII) is a powerful prognostic indicator in several malignancies. 6 The purpose of this work is to explore the correlation between PNI and SII and OSCC recurrence and prognosis, and the value of PNI and SII and their combined detection on OSCC recurrence and prognosis prediction. The data of 380 OSCC patients was collected. Inclusion criteria: (1) Patients with primary oral tumor and diagnosed as squamous cell carcinoma by pathological examination; (2) Patients with age over 18 years old; (3) Patients received systematic treatment in our hospital; (4) Patients with complete clinical, pathological, and follow-up data; (5) Patients with clinical stage III~IV. Exclusion criteria: (1) Patients with serious underlying diseases; (2) Patients with a history of other malignant tumors; (3) Patients with active infection or inflammatory disease within 4 weeks before surgery; (4) Patients lost to follow-up. 298 patients were finally included in this study. The study was approved by XXX, and all the participants signed the informed written consent. Recurrence is defined as in situ (local) recurrence of malignancy of the same histological origin in the in situ or neck or in situ + neck or distant area at least 4 weeks after the first standard surgical treatment. Recurrence was diagnosed through physical examination, magnetic resonance imaging (MRI), computed tomography (CT), and pathological examination. Distant metastases were diagnosed through medical history, clinical signs, positron emission tomography (PET), and CT. TNM staging criteria for OSCC patients: based on the 2017 AJCC/UICC oral cancer TNM staging criteria combined with previous cl -Abstract Truncated-

Systemic immune-inflammation and prognostic immune nutritional index in oral squamous cell carcinoma patients

Correlations of preoperative systematic immuno-inflammatory index and prognostic nutrition index with a prognosis of patients after radical gastric cancer surgery

Correlation of Prognostic Nutritional Index and Systemic Immune-Inflammation Index with the Recurrence and Prognosis in Oral Squamous Cell Carcinoma with the Stage of III/IV

Prediction of severe radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma using the combined systemic immune-inflammatory index and prognostic nutritional index

Prognostic and clinicopathological role of pretreatment systemic immune-inflammation index in patients with oral squamous cell carcinoma: a meta-analysis

Pretreatment systemic immune-inflammation index and lymphocyte-to-monocyte ratio as prognostic factors in oral cavity cancer: A meta-analysis

Prognostic value of the systemic immune-inflammation index, systemic inflammation response index, and prognostic nutritional index in head and neck cancer

The Systemic Immune-Inflammation Index as an Independent Predictor of Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Radiotherapy

Prognostic impact of the prognostic nutritional index in cases of resected oral squamous cell carcinoma: a retrospective study

Prognostic value of inflammatory nutritional scores in locally advanced esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multicenter study in China

Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer

Prognostic value of systemic immune-inflammation index in patients with gastric cancer

Effects of nutritional indices and inflammatory parameters on patients received immunotherapy for non-small cell lung cancer

Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma

Nutritional and immune-related indicators-based Nomogram for predicting overall survival of surgical oral tongue squamous cell carcinoma

Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC

Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy

Combined systemic immune-inflammatory index and prognostic nutritional index predicts the efficacy and prognosis of ES-SCLC patients receiving PD-L1 inhibitors combined with first-line chemotherapy

Prognostic value of systemic immune-inflammation index and systemic inflammation response index for oral cancers: A systematic review and meta-analysis

Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer

The Systemic Immune-Inflammation Index and Albumin as Prognostic Predictors in Laryngeal Carcinoma